TABLE C-3 Mercury Content from Thimerosal in Other Licensed Vaccines in the United States, April 2004

Vaccine

Brand Name

Manufacturer

Hg [μg/dose]

Anthrax

BioThrax

BioPort Corporation

0

Smallpox

Dryvax

Wyeth

0

BCG*

 

Organon Tecknika

0

Mycobax

Aventis Pasteur, Ltd

0

Hepatitis A-Hepatitis B

Twinrix

Glaxo-SmithKline

<1 μg

Hepatitis B

Engerix B

(adult formulation)

Glaxo-SmithKline

< 0.5

 

Recombivax HB

(adult formulation)

Merck

25

 

Recombivax HB

(adult formulation)

Merck

0

Lyme*

LYMErix

Glaxo-SmithKline

0

Meningococcal1

Menomune A, C,

AC and A/C/Y/W-135

Aventis Pasteur, Inc.

(multidose)

25

 

Single dose

0

Rabies

IMOVAX

Aventis Pasteur SA

0

Rabavert

Chiron Behring

0

Typhoid Fever

Typhim Vi

Aventis Pasteur SA

0

Vivotif Berna

Berna Biotech, Ltd.

0

Yellow Fever

YF-VAX

Aventis Pasteur, Inc.

0

Japanese Encephalitis Vaccine

JE-VAX

Aventis Pasteur, Inc.

35

*Not available in the United States.

1Menomune A/C/Y/W-135, a thimerosal-containing vaccine, is not indicated for infants and children younger than 2 years of age except as short-term protection of infants 3 months and older against Group A. (Physician’s Desk Reference, 2001).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement